Purpose: We described and compared the frequency and type of lower urinary tract symptoms reported by men and women at the time that they were recruited from urology and urogynecology clinics into the Symptoms of Lower Urinary Tract Dysfunction Research Network multicenter, prospective, observational cohort study. Materials and Methods: At 6 research sites treatment seeking men and women were enrolled who reported any lower urinary tract symptoms at a frequency more than rarely during the last month on the LUTS (Lower Urinary Tract Symptoms) Tool. At baseline the study participants underwent a standardized clinical evaluation and completed validated questionnaires. Urological tests were performed, including pelvic/rectal examination, post-void residual urine measurement and urinalysis. Results: A total of 545 women and 519 men were enrolled in the study. Mean AE SD age was 58.8 AE 14.1 years. At baseline nocturia, frequency and a sensation of incomplete emptying were similar in men and women but men experienced more voiding symptoms (90% vs 85%, p ¼ 0.007) and women reported more urgency (85% vs 66%, p <0.001). Women also reported more of any type of urinary incontinence than men (82% vs 51% p <0.001), which was mixed incontinence in 57%. Only 1% of men reported stress incontinence but they had other urinary Accepted for publication October 24, 2017. No direct or indirect commercial incentive associated with publishing this article. The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
THE term LUTS includes a wide range of urinary symptoms such as urgency, frequency, dysuria, nocturia, post-void dribbling and UI. The population prevalence and incidence of LUTS vary depending on patient gender, age, ethnicity and many other factors. For example, in the BACH Survey, a community based, prospective cohort study, LUTS had developed in 1 of 10 adults at the 5-year followup. 1 Symptoms were significantly more prevalent in women and nonwhite minorities 1 with a sharp increase with advancing age. Primarily due to an aging American population Ganz et al estimated that in 2020 the total national cost of overactive bladder symptoms alone would exceed $82 billion annually. 2 Importantly LUTS also adversely affect mental and physical quality of life. 3e5 There is a large knowledge gap in the understanding of the pathophysiology of LUTS and, therefore, treatments are often inadequate. 6 LURN (https://nih-lurn.org/) was established to better characterize the type, frequency and distribution of LUTS, and patient experience with LUTS. The 4 objectives were to 1) identify and explain the important subtypes of LUTS in a treatment seeking cohort, 2) create more specific and sensitive validated measuring tools of patient experience with LUTS, 3) disseminate novel findings to researchers, clinicians and patients, and 4) generate data, research tools and biological samples for future studies. 7 To our knowledge no previously published, longitudinal studies of LUTS have included men and women who were seeking care. A care seeking population is expected to be distinct from population studies and uniquely important since these patients are significantly bothered by symptoms. The types and distribution of symptoms that drive persons to seek care may be distinct from those experienced by persons in the community at large.
The primary purpose of this specific report of the baseline symptoms and methodology of LURN was to describe LUTS in a cohort of treatment seeking men and women. Secondary aims were to compare reported LUTS between males and females as well as how they differ by age.
METHODS
The institutional review boards at all participating sites approved the protocol of the LURN Observational Cohort Study. LURN is a multicenter, NIH NIDDK sponsored research network consisting of 6 American research sites and a data coordinating center. LURN also includes an External Expert Panel which provides oversight for all LURN protocols.
This treatment seeking cohort of men and women was recruited from January 2015 through January 2017 from patients who presented for care at tertiary referral centers for LUTS. All participants were at least 18 years old and primarily those presenting for the first time for treatment of LUTS to a LURN physician at a urology or urogynecology clinic. To accelerate recruitment the study protocol was modified to permit the recruitment of men returning to the clinic for treatment of LUTS (patients who were not first presenters). Patients were invited to participate if they reported at least 1 urinary symptom based on a 1-month recall period on the LUTS Tool. 8 The supplementary Appendix (http://jurology.com/) lists study inclusion and exclusion criteria. All participants provided written informed consent.
Data collection at the baseline clinic visit included standard clinical examination with digital rectal prostate examination in men, and POP-Q (Pelvic Organ Prolapse Quantification) and pelvic floor muscle assessment in women, using the Oxford grading system. All participants were screened with urinalysis and post-void residual urine measurement by catheterization or bladder ultrasound. Participants were instructed to withhold initiating new medical or surgical therapies for LUTS prior to the study visit and specimen collection.
At a separate study visit the data collected included patient reported urinary, pelvic floor and psychological symptoms. During this research visit demographic information collected on all participants included date of birth, gender, race, ethnicity, education, employment and marital status. Participants were queried regarding past medical and surgical history, diet, use of alcohol, tobacco and caffeine, obstetric history, menopausal status and use of hormone therapy. For each participant we calculated Functional Comorbidity Index findings from 18 diagnoses. 9 We collected family history among first-degree relatives who were diagnosed with and/or treated for LUTS. All current prescription and over-the-counter medications were recorded.
Participants completed a battery of validated survey instruments that assessed urinary and bowel function, generic health, mental health and other symptoms during the study visit. Supplementary table 1 (http://jurology. com/) outlines these survey instruments. 8,10e21 Participants also completed a 3-day fluid intake and urinary diary within 4 weeks of the baseline visit and before initiating any prescribed treatment. The diary recorded fluid intake, volume of urine voided, episodes of urinary leakage and whether leakage occurred with activity or urgency.
Our study was powered based on 4 basic types of hypothesis tests, including the t-test, logistic regression, correlations and the chi-square test. For the full 1,000-person cohort greater than 90% power was achieved to detect differences between groups as small as 0.3 SD for urinary symptom ratings using the t-test, ORs of 1.3 or proportions of 0.35 vs 0.50 for urinary symptom presence or absence using logistic regression or the chi-square test, respectively, when subgroups were split 50%-50% (eg by gender). For less prevalent group comparisons (eg diabetes or obesity) greater than 90% power was achieved for differences between groups as small as 0.4 SD for symptom ratings, ORs of 1.5 or proportions of 0.30 vs 0.50 for urinary symptom presence or absence when subgroups were split 90%-10%.
Study participants completed followup assessments with the instruments 3 and 12 months after the initial assessment to evaluate the trajectory of urinary symptoms in the context of the treatments that they received (supplementary Appendix, http://jurology.com/). Additional information collected at these time points included an interval clinical history which assessed any changes in medical or surgical therapy from the prescribed plan. The results presented in this study are limited to the baseline assessment.
Blood, saliva, urine and biological flora of patients are associated with LUTS. Specimens were prospectively collected, processed and stored at the NIDDK Biorepository for biomarker and other studies. The supplementary text (http://jurology.com/) describes specific details of biospecimen collection.
The primary measures of LUTS for this report were the validated LUTS Tool with a 1-week recall 8 and AUA SI. The latter was initially developed to assess the severity of LUTS associated with benign prostatic hyperplasia 10 but it has been used in women.
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Demographic and clinical characteristics of the LURN cohort are described using the mean AE SD for continuous variables, and the frequency and percent for categorical variables by gender and overall. Tests for differences by gender were performed using the chi-square test and the Wilcoxon 2-sample test. The frequency and percent of participant responses to the LUTS Tool and AUA SI questions were calculated by gender. Responses overall and the percent of responses to LUTS Tool severity items were graphed by gender using horizontal stacked bar charts.
UI subtype was determined from responses to questions 16 a to g on the LUTS Tool. Participants were classified as having SUI if they answered sometimes or more often on at least 1 of 2 questions related to experiencing leakage when they exercised, laughed, coughed or sneezed. Those who responded sometimes or more to leakage due to a sudden feeling of needing to rush to urinate were considered to have UUI. Patients were classified as having MUI if they fulfilled criteria for SUI and UUI. Finally, those who indicated leakage during sleep, sex, just after voiding or for no reason who did not meet the criteria for any of the mentioned groups were classified as having other UI.
RESULTS
Of the 3,461 patients screened from January 2015 to January 2017 a total of 2,201 were eligible for consent, of whom 1,231 consented. Supplementary tables 2 and 3 (http://jurology.com/) show the reasons for ineligibility and refusal of consent. Of those participants 150 were excluded from analysis because they did not complete the baseline clinical examination and 29 were excluded due to inadequate symptom reporting on the LUTS Tool, defined as completing less than two-thirds of the form. The final analytical sample comprised 1,064 participants, including 545 women and 519 men ( fig. 1) .
Overall the mean age of the cohort was 58.8 AE 14.1 years and 83% of the participants were white. Female participants were significantly younger than males (mean age 56.4 vs 61.2 years, p <0.001). The median BMI was 28.9 kg/m 2 (IQR 25.1e33.4) and 43% of all participants were categorized as obese with a BMI of 30 kg/m 2 or greater. A history of diabetes was more common in men than in women (19% vs 14%, p ¼ 0.073). A history of smoking was also more common in men (46% vs 35%, p <0.001).
Only 3% of the patients reported currently using antimuscarinic medications for the bladder. Almost a third of the women had previously undergone hysterectomy and 12% had already undergone a surgical procedure for incontinence or prolapse. Among the men 4% had undergone prostate surgery for benign conditions in the past while 39% and 15% reported using a-blockers and 5a-reductase inhibitors, respectively (see table) .
A comparison of responses to the LUTS tool by gender demonstrated that a greater number of women experienced more than rare incontinence on a weekly basis than men (67% vs 49%, supplementary table 4 and fig. 1 , http://jurology. com/). In contrast, men reported more voiding symptoms than women, including hesitancy (48% vs 24%), intermittency (53% vs 25%), straining (28% vs 19%) and a weak stream (61% vs 29%). Responses to AUA SI questions by gender showed patterns similar to those of the LUTS Tool (supplementary fig. 2 between groups, as was nocturia and a sense of incomplete bladder emptying ( fig. 2) .
After adjusting by gender nocturia was more likely to occur in older patients (OR 1.39/10-year age increase, 95% CI 1.27e1.52), as was fear of leakage due to urgency (OR 1.21/10-year age increase, 95% CI 1.10e1.33) and UUI (OR 1.17/10-year age increase, 95% CI 1.06e1.28). After adjusting by gender younger patients had greater odds of leakage with sexual activity (OR 0.77/10-year age increase, fig. 3 ). UI type was determined in 481 men and 509 women who completed all 7 questions related to incontinence on the LUTS Tool (16 a to g). Overall UI combined was more common in women than in men (82% vs 51%). SUI was more common in women and other UI was more common in men. The most common type of UI in women with UI was MUI at 57%, followed by UUI at 20% (fig. 4) . In contrast, 46% of the men with leakage had UUI and 44% had other UI. In most of the latter cases UI consisted of post-void dribbling. SUI was noted in 2 of the 243 men with UI and MUI was noted in 22.
DISCUSSION
Our results show that LUTS in treatment seeking men and women vary not only with gender but also with age. Overall UI is more prevalent in women while men report more voiding symptoms.
Gender specific urinary symptom characteristics have been reported in studies similar to ours. 1, 5, 23 In this cohort incontinence of any type was more common in women than in men. However, surprisingly more than half of all men reported some degree of incontinence, which was mainly post-void dribbling but also UUI. Women more commonly reported SUI. This is not surprising, given that 20% of women will undergo surgery for SUI or pelvic organ prolapse in a lifetime. 24 Our finding that women more often report UI is qualitatively similar to results in the BACH Survey, a community based study of racially diverse men and women, in which 10.4% of women and only 5.3% of men reported urinary leakage.
1 Not Figure 2 . Female vs male LUTS symptom ORs adjusted for age from bivariate logistic regression models. Squares represent ORs comparing female with male participants on log-odds scale for each item on LUTS Tool and AUA SI (asterisk). Lines extend to lower and upper 95% CIs. Using false discovery rate (FDR) method p values were adjusted for multiple comparisons.
surprisingly, the overall prevalence of incontinence was lower in the BACH Survey compared with our cohort since the former study enrolled persons living in the community rather than tertiary care, treatment seeking patients. Several urinary symptoms affected men and women similarly. Urinary frequency, nocturia and a sense of incomplete bladder emptying were common in persons of each gender. This challenges the common misconception that women experience more LUTS than men. 22, 25, 26 When adjusting for gender in our cohort, nocturia was a more common complaint among older patients. These findings are similar to those in a study by Fitzgerald et al, who also reported that nocturia was common in a community based population. 27 On their multivariate analysis the odds of nocturia increased with age and were lower in men (OR 0.79, 95% CI 0.65e0.97). However, we found that the odds of nocturia did not significantly differ between men and women. This could have been due to a broader age demographic and to inherent population differences in a treatment seeking cohort.
This report has several strengths and limitations. The individuals in this cohort represent a fraction of the treatment seeking patients seen at tertiary care urology or urogynecology clinics and they were mostly white. Thus, our findings may not be generalizable to the general population of patients who seek care with primary care physicians. Our definitions of incontinence and incontinence type as well as LUTS were based only on patient self-report and not corroborated by any objective testing such as urodynamic studies. This report also did not include controls who were not seeking treatment to serve as a comparison group.
The strengths of this study are our large, mixed gender cohort with a detailed medical and surgical history as well as the duplicative questionnaires covering patient urinary symptoms. Data collected as part of this cohort but which are not presented include a wealth of information on many other aspects of participant nonurological history and symptoms. Those data will be used to explore relationships between these patients and LUTS. Additionally, studies on biological samples, bladder diaries and the longitudinal portion of the study will further supplement our understanding of LUTS in this group. Our findings in future reports will be a useful guide to health care providers in the management of LUTS in men and women who present for treatment.
CONCLUSIONS
LURN has successfully recruited a large cohort of treatment seeking men and women with LUTS. Study participants completed a detailed, standardized assessment, which provides a novel opportunity to identify and study LUTS and other potentially associated symptoms that will be the subject of future reports. These initial analyses indicate that LUTS vary widely by gender and age. While this variation was similar to that in prior population based studies, the prevalence of symptoms was higher in our cohort. 
